Indiana Medicaid to Cover GLP-1s for Obesity Under Federal Initiative
Indiana will cover GLP-1 medications for obesity through its Medicaid program serving 1.9 million enrollees. Governor Mike Braun directed the Family and Social Services Administration to participate in a CMS Innovation Center initiative expanding access to these medications beyond diabetes treatment. The coverage expansion affects benefit design, formulary management, and utilization management protocols for Indiana's Medicaid program. This marks a significant pharmacy policy shift as states weigh high-cost obesity treatment coverage under federal demonstration authority.
This expands pharmacy benefits and prior authorization protocols for Indiana's managed care plans and fee-for-service program, with direct implications for formulary design, spending forecasts, and access policies around high-cost weight management drugs.
Pharmacy · Managed Care
You might also like